DCA seizes syrup stocks over misleading fever cure claim

Officials from the Telangana Drugs Control Administration (DCA) have seized stocks of a syrup marketed as a cure for ‘all types of fevers’, citing violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

During a raid conducted on May 14 at a medical store in Adilabad, the DCA officers found the product, ‘Herbal Fever Guard Syrup’ being sold with a label that falsely claimed it could treat all types of fevers. The medicine is manufactured and marketed by International Herbal Corporation Private Limited, based in Haridwar, Uttarakhand, said a release.

Authorities said the product’s label amounts to a misleading advertisement, which is prohibited under the 1954 Act. The law explicitly bans advertisements that promote medicines as treatments for certain diseases and conditions, including fevers in general. As per the Act, no person is allowed to participate in the publication or circulation of such advertisements.

Stocks of the syrup were seized on the spot, and further investigation is underway, the release stated.

Related Posts

  • Pharma
  • June 25, 2025
  • 99 views
Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

A major face-off is expected in India’s growing anti-obesity treatment market, as Danish pharma giant Novo Nordisk rolled out its blockbuster weight-loss drug Wegovy on Tuesday, just a month after…

  • Pharma
  • June 25, 2025
  • 110 views
Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Hyderabad:  Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharma launches TEVIMBRA in India